Venous Thromboses Clinical Trial
— ETERecaVSPTOfficial title:
Exercise Tolerance After Venous Recanalization for Post-thrombotic Syndrome: ETERecaVSPT
Post-thrombotic syndrome (PTS) is the most frequently observed chronic complication of deep vein thrombosis (DVT), with an estimated cumulative incidence of 20-50%. Endovascular venous recanalization with angioplasty and stenting of obstructive lesions is the recommended treatment option to reduce or correct the symptoms of DVT. However, its impact on the physical capacity and breathlessness of patients has not been fully demonstrated. The heterogeneous evidences of clinical improvement is probably related to the presence or absence of collateral veins developed in these patients with proximal venous obstruction (iliac or iliofemoral with or without inferior vena cava involvement), which ensure the cardiac venous return. The aim of this study is to compare changes in maximal oxygen uptake after endovascular venous recanalization in DVT patients and to evaluate the hemodynamic, respiratory and muscular improvement induced by the restoration of venous flow in the occluded segments.
Status | Recruiting |
Enrollment | 22 |
Est. completion date | December 17, 2025 |
Est. primary completion date | June 17, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient eligible for endovascular treatment for post-thrombotic syndrome in a chronic context (6 months after the occurrence of thrombosis, without time limit), after validation of the indication during a monthly medical-radiological PCR (St Eloi vascular medicine team and vascular radiologist performing the endovascular treatment) - Age >= 18 years Exclusion Criteria: - Contraindication to the performance of a maximal effort test on a cyclo-ergometer - Refusal of consent after information - Adult protected by law (guardianship, curatorship) - Pregnant or breastfeeding woman - Patient not affiliated to a social security system or not benefiting from such a system |
Country | Name | City | State |
---|---|---|---|
France | Hopital Arnaud de Villeneuve - CHU de Montpellier | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | VO2 max | Change in VO2 max is the maximum (max) rate (V) of oxygen (O2) the body is able to use during exercise from baseline to 8 weeks. It is measured in liters of O2 per minute | From baseline and 8 weeks | |
Secondary | Maximum aerobic power (in Watts) | Maximum aerobic power is measured in watts before and after venous recanalization | From baseline and 8 weeks | |
Secondary | Isowork power | The isowork power is the power output assessed at the V'O2max before recanalization | From baseline and 8 weeks | |
Secondary | Maximal exercise cardiac output (in litres per minute) | Maximal exercise cardiac output is the cardiac output assessed by thoracic impedance et peak exercise before and after venous recanalization | From baseline and 8 weeks | |
Secondary | Exercise change in Inspiratory capacity (in litres) | Exercise change in Inspiratory capacity is the change between rest and peak exercise of the inspiratory capacity (the volume between end-expiratory volume and total lung capacity) before and after venous recanalization | From baseline and 8 weeks | |
Secondary | Maximal exercise capillary volume (in millilitres) | Maximal exercise capillary volume is the capillary volume at peak exercise assessed by NO/CO transfer before and after venous recanalization | From baseline and 8 weeks | |
Secondary | Maximal exercise O2 arterial pressure (PaO2, in mmHg) | Maximal exercise O2 arterial pressure is the oxygen partial pressure in the arterial blood, assessed at peak exercise, before and after venous recanalization | From baseline and 8 weeks | |
Secondary | Maximal isometric torque during leg extension (in Newton.meters) | Maximal isometric strength during leg extension is the maximal torque of the leg extension at 90° knee flexion assessed by a torque sensor before and after venous recanalization | From baseline and 8 weeks | |
Secondary | Lower limb extracellular/total water (in %) | Lower limb extracellular/total water is the water volume int the body compartments in each lower limb, assessed by a segmental bioelectrical impedancemeter before and after venous recanalization | From baseline and 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03613402 -
BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes
|
||
Recruiting |
NCT05409976 -
The GORE® VIAFORT Vascular Stent IVC Study
|
N/A | |
Completed |
NCT03015025 -
Pharmacogenetic Dosage Algorithm for Acenocoumarol
|
N/A | |
Completed |
NCT03911661 -
Fearon Algorithm in Warfarin Patient Self-Management
|
N/A | |
Recruiting |
NCT05449808 -
Evaluation of Thromboprophylaxis Appropriateness in Hospitalized Medical Patients
|
||
Withdrawn |
NCT05246943 -
The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients
|
||
Recruiting |
NCT01339611 -
Education Program for Patients Receiving Oral Anticoagulation
|
N/A | |
Completed |
NCT04367831 -
Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
|
Phase 4 | |
Recruiting |
NCT05711173 -
Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
|
N/A | |
Completed |
NCT04824118 -
Clotting Parameters After Medical Abortion
|
||
Withdrawn |
NCT01810237 -
Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy
|
N/A | |
Recruiting |
NCT05489588 -
The GORE® VIAFORT Vascular Stent Iliofemoral Study
|
N/A | |
Completed |
NCT05087108 -
Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow
|
Early Phase 1 | |
Terminated |
NCT04128956 -
Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS
|
Phase 2 | |
Completed |
NCT04439383 -
Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
|
||
Not yet recruiting |
NCT06452342 -
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study
|
Phase 4 | |
Recruiting |
NCT06087952 -
Leiden Thrombosis Recurrence Risk Prevention
|
N/A | |
Completed |
NCT05515120 -
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
|
Phase 2/Phase 3 | |
Completed |
NCT03611894 -
Comparison of the Radiological Pattern Between the Cerebral Stroke of Arterial and Venous Origin
|
||
Completed |
NCT03835780 -
The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
|